{"id":49838,"date":"2026-05-07T10:43:52","date_gmt":"2026-05-07T08:43:52","guid":{"rendered":"https:\/\/wellclinic.pl\/?p=49838"},"modified":"2026-06-12T13:51:47","modified_gmt":"2026-06-12T11:51:47","slug":"mounjaro-effects-before-and-after-weight-loss-and-weight-struggle","status":"publish","type":"post","link":"https:\/\/wellclinic.pl\/en\/mounjaro-efekty-przed-i-po-odchudzanie-i-walka-z-nadwaga\/","title":{"rendered":"Mounjaro effects before and after - weight loss and weight management"},"content":{"rendered":"

The treatment of obesity has undergone a significant change in recent years through the development of metabolic pharmacotherapy. Drugs that not only promote weight loss, but also affect mechanisms regulating appetite, satiety and glucose metabolism are playing an increasingly important role. One of the most commonly discussed preparations is Mounjaro<\/strong>. In a clinical context Mounjaro effects before and after<\/strong> is primarily assessed in the long term, as metabolic changes occur gradually and depend on the regularity of therapy and the patient's lifestyle. Patients very often enter the phrase \u201eMounjaro effects before and after<\/strong>\u201d to see what the real course of therapy looks like. However, it should be emphasised that the effects are not immediate and show a clear dependence on the dose, lifestyle and individual response of the body. In some patients, the first effects are subtle and mainly concern a reduction in appetite rather than the loss of weight itself.<\/p>\n\n\n\n

How does Mounjaro work?<\/h2>\n\n\n\n

Mounjaro<\/strong> contains thiothiazolidine, a substance that acts on two hormonal mechanisms - GIP and GLP-1. It is the action of these two hormones that is responsible for its effectiveness in reducing body weight and improving metabolic parameters. This mechanism influences the satiety centre in the brain, leading to a faster onset of feelings of fullness. This reduces appetite and patients spontaneously consume fewer calories. Compared to GLP-1-only therapies such as semaglutide, thiothiazolidine shows a broader metabolic effect, which in clinical trials often translates into greater weight reduction, although the body's response remains individual. In many patients using Mounjaro<\/strong> there is also a stabilisation of energy levels throughout the day and a reduced need to snack between meals, which is important for long-term weight control.<\/p>\n\n\n\n

Mounjaro and the treatment of type 2 diabetes<\/h2>\n\n\n\n

Thiogastatide was originally developed in the context of the treatment of type 2 diabetes, and therefore its effects also include improving carbohydrate metabolism. Some patients show improved glycaemic control and a reduction in HbA1c values. This is particularly important in the context of people with type 2 diabetes, in whom weight reduction and improved metabolism reduce the risk of cardiovascular complications. In clinical practice, treatment is carried out as prescribed by the physician, and regular monitoring of parameters such as sugar and HbA1c allows the effectiveness of the therapy to be assessed.<\/p>\n\n\n\n

First effects of Mounjaro<\/h2>\n\n\n\n

During application Mounjaro<\/strong> The first effects are not immediately related to weight reduction. In the first weeks of therapy, a reduction in appetite and easier portion control are most often observed. Many patients also experience a quicker feeling of satiety after meals due to the action on the satiety centre in the brain. As a result, energy intake is reduced without the need for restrictive diets. At this stage of treatment, it is important to keep the body adequately hydrated and to avoid sudden changes in the calorie content of the diet as the body adapts to the new hunger regulation mechanism.<\/p>\n\n\n\n

\n
Find out more<\/a><\/div>\n<\/div>\n\n\n\n

First weeks of application<\/h2>\n\n\n\n

Clinical studies show that the therapy can lead to an average weight reduction of 15-22%<\/strong> in the long term. The rate of change depends on the dose, diet and level of physical activity.<\/p>\n\n\n\n

Weight reduction<\/strong> mainly concerns adipose tissue, including visceral fat, excess of which is associated with an increased risk of metabolic diseases.<\/p>\n\n\n\n